Needham reiterated coverage on Genocea Biosciences with a new price target

2/11/21 11:14:26 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Needham reiterated coverage of Genocea Biosciences with a rating of Buy and set a new price target of $6.00 from $7.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GNCA

Date	Price Target	Rating	Analyst